Order results by:
| Issue | Title | |
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Art therapy possibilities in the complex treatment of patients with multiple sclerosis | Abstract similar documents |
| M. E. Guseva, O. V. Matvievskaya, A. N. Boyko | ||
| "... ). Results and discussion. Before the art therapy start, light blue, yellow, pink, blue, and green colors ..." | ||
| Vol 11, No 4 (2019) | Metamorphopsia in neurological practice | Abstract similar documents |
| V. N. Grigoryeva, K. A. Mashkovich | ||
| "... , orientation, color, and/or motion parameters), but without affecting their essential characteristics. It can ..." | ||
| Vol 11, No 3 (2019) | Early cognitive dysfunction as a marker for the poor course of multiple sclerosis: a prospective 12-year follow-up | Abstract similar documents |
| D. S. Kasatkin, S. S. Molchanova, N. N. Spirin | ||
| "... -year risk of reaching 6.5 Expanded Disability Status Scale (EDSS) scores. Patients and methods ..." | ||
| Vol 11, No 1 (2019) | Experience with anti-B-cell therapy in the pathogenetic treatment of multiple sclerosis | Abstract PDF (Eng) similar documents |
| O. V. Boyko, S. V. Petrov, N. Yu. Lashch, M. R. Guseva, A. N. Boyko | ||
| "... Expanded Disability Status Scale (EDSS) score was 4.0; the most severe course of the disease was observed ..." | ||
| Vol 16, No 3 (2024) | Diffusion tensor tomography with tractography in assessment of the pyramidal system in patients with highly active multiple sclerosis | Abstract similar documents |
| A. N. Peshkin, G. T. Toniya, E. A. Stepanova, V. Yu. Lizhdvoi, S. V. Kotov | ||
| "... functional system (PFS) impairment according to EDSS, patients were divided into 2 groups; group 1 — 17 ..." | ||
| Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Non-drug therapies for cognitive impairment | Abstract similar documents |
| I. S. Preobrazhenskaya, D. Fantalis, S. A. Abdyshova, A. A. Kindarova | ||
| Vol 13, No 6 (2021) | Changes in retinal structures as markers of multiple sclerosis progression | Abstract similar documents |
| M. O. Poplyak, A. G. Trufanov, A. V. Temniy, D. S. Maltsev, O. B. Chakchir, A. V. Mikheev, D. I. Skulyabin, G. N. Bisaga, I. V. Litvinenko, M. M. Odinak | ||
| "... Status Scale (EDSS) and the Multiple Sclerosis Severity Score (MSSS). All patients were examined ..." | ||
| Vol 7, No 1 (2015) | Time course of changes in the development of gait disorders in multiple sclerosis | Abstract similar documents |
| A. M. Petrov, I. D. Stolyarov, G. G. Shkilnyuk, A. G. Ilves, K. K. Mineev, V. V. Lebedev, T. L. Tsvetkova | ||
| "... was evaluated using the expanded disability status scale (EDSS); pedographic examination was made applying ..." | ||
| Vol 16 (2024): (Suppl. 2) | High-dose immunosuppressive therapy followed by haematopoietic stem cell transplantation as a method for the treatment of refractory forms of neuromyelitis optica spectrum disorder in children | Abstract similar documents |
| N. N. Bronina, O. V. Bykova, G. O. Bronin, A. E. Kessel, G. Z. Seregin, K. I. Kirgizov, A. Yu. Polushin, T. T. Batysheva | ||
| "... ’s neurological deficit progressed to 9.5 points on the Expanded Disability Status Scale (EDSS). After ..." | ||
| Vol 8, No 3 (2016) | Epidemiology of multiple sclerosis in the Bryansk Region | Abstract similar documents |
| Yu. N. Yurchenko, A. N. Yurchenko, I. V. Smagina | ||
| "... Hospital One. The Expanded Disability Status Scale (EDSS) was used to evaluate the severity of the disease ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Experience with cladribine tablets for highly active multiple sclerosis in everyday clinical practice | Abstract similar documents |
| S. V. Petrov, O. V. Boyko, A. N. Boyko | ||
| "... , cervical and thoracic spine, and chest X-ray, Expanded Disability Status Scale (EDSS) scoring, clinical ..." | ||
| Vol 17, No 4 (2025) | Hyperhomocysteinemia and endothelial dysfunction in multiple sclerosis | Abstract similar documents |
| E. A. Dubchenko, A. N. Boyko, A. V. Ivanov, M. A. Popov, R. A. Maslennikov, M. P. Kruglova, E. V. Silina, E. I. Gusev, A. A. Kubatiev | ||
| "... the EDSS scale, and the disease progression index was calculated. The following biomarkers were also ..." | ||
| Vol 15 (2023): (Suppl. 1) | Distinctive parameters of gait in patients with multiple sclerosis, depending on the profile of its dysfunction | Abstract similar documents |
| S. A. Ryabov, A. N. Boyko | ||
| "... in the EDSS range up to 5.5 points – the step width, the value of which is greater in patients with ataxia ..." | ||
| Vol 17, No 4 (2025) | Cognitive changes in multiple sclerosis and factors of their development: association with taking disease-modifying therapies | Abstract similar documents |
| A. O. Komissarenko, V. V. Grinyuk, A. S. Bakhchivanov, E. V. Yashchuk, E. S. Fatueva, K. Yu. Komissarenko, N. V. Vakhnina, V. V. Zakharov, N. S. Babieva | ||
| "... , prolonged course of the disease, high degree of disability according to EDSS. Modifiable risk factors for CI ..." | ||
| Online-first | From pathogenesis and research to the treatment of secondary progressive multiple sclerosis in clinical practice: switching from anti-CD20 monoclonal antibody therapy to siponimod (clinical case) | Abstract similar documents |
| E. V. Popova | ||
| "... progression on the EDSS scale from 4.5 to 6.0 points over 3 years of therapy. In this regard, the patient ..." | ||
| Vol 16 (2024): (Suppl. 2) | Multifactorial model of predictors of the development of depressive disorders in multiple sclerosis: a prospective longitudinal study | Abstract PDF (Eng) similar documents |
| K. V. Gubskaia, Yа. V. Malygin, A. Yu. Aleksandrova | ||
| "... scale (VAS) for pain, PASAT test, EDSS. We performed an MRI scan, and identified significant stressful ..." | ||
| Vol 17, No 3 (2025) | Curcumin as add-on therapy in patients with multiple sclerosis showing a suboptimal response to first-line disease-modifying therapies: clinical outcomes and in vitro data | Abstract similar documents |
| A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaia, E. V. Lysogorskaia, A. N. Boyko | ||
| "... additional therapy with micellar curcumin for 6 months (IFN-C group). Clinical (relapses, MRI activity, EDSS ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Clinical presentation and course of multiple sclerosis in patients with herpesvirus infection | Abstract similar documents |
| M. S. Gris, N. S. Baranova, N. N. Spirin, D. S. Kasatkin, D. V. Kiselev, E. G. Shipova | ||
| "... .47 years), mean Expanded Disability Status Scale (EDSS) score – 2.91±1.67. 86% of patients had relapsing ..." | ||
| Vol 16, No 3 (2024) | Experience of cladribine tablets usage in the treatment of multiple sclerosis in the Multiple Sclerosis Centre of the Khanty-Mansi Autonomous Area — Yugra | Abstract similar documents |
| A. A. Sokolova, L. I. Anischenko, L. S. Zemlyanushin, E. A. Rubtsova | ||
| "... Scale (EDSS), complete blood count, monitoring of blood lymphocytes level and biochemical blood testing ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Clinical and epidemiological characteristics of multiple sclerosis in students in the Republic of Bashkortostan | Abstract similar documents |
| A. V. Tukhvatullin, U. Sh. Kuzmina, N. F. Utyagulova, R. F. Talisov, V. A. Vakhitov, K. Z. Bakhtiyarova | ||
| "... and cerebellar ataxia. Students also had a faster MS progression (0.4 [0.2; 0.6] EDSS scores per year, p=0 ..." | ||
| Vol 12, No 1 (2020) | Association of BAFF gene polymorphisms with multiple sclerosis progression | Abstract PDF (Eng) similar documents |
| I. V. Smagina, S. A. Elchaninova, A. S. Palashchenko | ||
| "... risk of a>0.75 point disability increase in the Expanded Disability Status Scale (EDSS) score ..." | ||
| Vol 7, No 1S (2015): Special issue "Epilepsy" | Epilepsy in patients with multiple sclerosis: specific features of diagnosis and therapy | Abstract similar documents |
| Yu. A. Belova, T. I. Yaukushina, I. G. Rudakova, S. V. Kotov | ||
| "... imaging (MRI) (at least 1.5 T) and electroencephalography (EEG), EDSS health assessment, antiepileptic ..." | ||
| Vol 15 (2023): (Suppl. 1) | Features of multiple sclerosis in childhood in the Republic of Tatarstan | Abstract similar documents |
| A. R. Khaibullina, F. A. Khabirov, T. I. Khaibullin | ||
| "... condition was assessed using the Expanded Disability Status Scale (EDSS). Results. MS was diagnosed in 99 ..." | ||
| Vol 15, No 3 (2023) | Impact of depression on the quality of life of patients with multiple sclerosis | Abstract similar documents |
| N. V. Zarubina, N. N. Spirin | ||
| "... 15 to 60 years (mean age 39.7±10.91 years). Disability according to the EDSS scale was 2.51±1 ..." | ||
| Vol 16 (2024): (Suppl. 2) | Results of tele-rehabilitation in patients with multiple sclerosis during 2020–2021 COVID-19 pandemic | Abstract similar documents |
| S. A. Sivertseva, K. S. Anfilofeva, A. V. Zotova, V. D. Chukreev, A. Yu. Belkina, L. I. Volkova, M. E. Guseva, A. N. Boyko | ||
| "... of patients who participated in TeleRBT, the level of disability on the EDSS scale did not change; walking ..." | ||
| Vol 16, No 5 (2024) | Efficacy and safety of cladribine tablets in multiple sclerosis in real-world clinical practice | Abstract similar documents |
| A. N. Peshkin, S. V. Kotov, G. T. Toniya, M. V. Sutormin, A. F. Eltayoury | ||
| "... year of treatment and by 97.4% after the second year of treatment. The mean EDSS score was 3.2±2 ..." | ||
| Vol 17, No 4 (2025) | Experience with the use of sampeginterferon beta-1a in real clinical practice in the Moscow region | Abstract similar documents |
| A. N. Peshkin, V. Yu. Lyzhdvoy, S. V. Kotov, M. V. Sutormin | ||
| "... in neurological deficit on the EDSS scale throughout the observation period. All recorded adverse reactions were ..." | ||
| Vol 16, No 2 (2024) | Effects of rehabilitation on functional independence in daily life, exercise tolerance and quality of life in patients with relapsing-remitting multiple sclerosis | Abstract similar documents |
| Ya. G. Pekhova, M. Yu. Martynov, I. A. Belayeva, A. S. Ryabov, A. A. Vershinin, A. N. Boiko | ||
| "... and 5 men; age – 41.6±7.7 years; EDSS – 4.0 [3.5; 5.0] points, duration of MS – 8.0 [3.0; 21.0] years ..." | ||
| Vol 16 (2024): (Suppl. 2) | Pain in patients with neuromyelitis optica spectrum disorders | Abstract similar documents |
| E. S. Novikova, A. S. Kotov, S. V. Kotov | ||
| "... and severity of the pain syndrome: Expanded Disability Status Scale (EDSS), Diagnostic Neuropathic Pain ..." | ||
| Vol 16 (2024): (Suppl. 2) | Curcumin as an add-on therapy for multiple sclerosis in patients receiving interferon-beta therapy | Abstract similar documents |
| A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaya, E. V. Lysogorskaia, A. N. Boyko | ||
| "... on the EDSS scale, the severity of chronic fatigue on the MFIS scale, the quality of life on the SF-36 scale ..." | ||
| Vol 13, No 4 (2021) | Anti-B-cell therapy in patients with neuromyelitis optica spectrum disorders | Abstract PDF (Eng) similar documents |
| S. V. Kotov, E. S. Novikova, A. S. Kotov | ||
| "... by the average annualized relapse rate, the median changes of the Expanded Disability Status Scale (EDSS ..." | ||
| Vol 16 (2024): (Suppl. 2) | Experience with the use of cladribine tablets in real-life clinical practice: independent analysis of data from 12 Russian clinical centres | Abstract similar documents |
| A. N. Boyko, V. M. Alifirova, D. V. Pashkovskaya, E. I. Kuchina, S. A. Sivertseva, E. L. Turova, Z. A. Goncharova, O. Yu. Rudenko, Yu. Yu. Pogrebnova, F. A. Khabirov, T. I. Khaibullin, N. N. Babicheva, N. L. Khoroshilova, O. V. Dzundza, O. A. Soldatova, A. N. Belova, G. Е. Sheiko, A. Е. Makarova, N. G. Glavinskaya | ||
| "... of exacerbations and an increase in Expanded Disability Status Scale (EDSS) scores prior to being prescribed ..." | ||
| Vol 17, No 4 (2025) | The role of central vein sign in differential diagnostics of neuromyelitis optica spectrum disorders and multiple sclerosis | Abstract similar documents |
| S. V. Kotov, E. S. Novikova, G. T. Tonya, A. S. Kotov | ||
| "... . The Expanded Disability Status Scale (EDSS) was used to assess neurological status. In addition to the routine ..." | ||
| Vol 6, No 3 (2014) | Visual evoked potentials in examining the visual analyzer in patients with multiple sclerosis | Abstract similar documents |
| S. M. Karpov, Z. B. Pazhigova, E. N. Karpova | ||
| "... increase occurs in response to the color spectrum of visible light against the black-white background ..." | ||
| Vol 15, No 3 (2023) | Parkinson’s disease. Focus on early stages | Abstract similar documents |
| E. A. Katunina, Z. A. Zalyalova, D. V. Pokhabov, M. Z. Ivanova, A. M. Semenova | ||
| "... such as parasomnia, constipation, hyposmia, anxiety-depressive disorder, daytime sleepiness, color perception changes ..." | ||
| Vol 12, No 6 (2020) | Cognitive and emotional impairment in patients with migraine and signs of leukoencephalopathy during preventive therapy | Abstract similar documents |
| K. A. Pozhidaev, V. A. Parfenov | ||
| "... color test) and studies of emotional disorders (the Beck Depression Inventory (BDI), the Center ..." | ||
| 1 - 36 of 36 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
